Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 3/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21915588 | 0.87 | ALOX5 (0.33) | ALOX5NPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21915850 | 0.82 | ALOX5 (0.38) | ALOX5CYP1A2CYP2C9CYP2C19PRKDC | |
| SCHEMBL21915383 | 0.81 | ALOX5 (0.35) | ALOX5PRKDC | |
| SCHEMBL21915594 | 0.81 | ALOX5 (0.36) | ALOX5CYP1A2CYP2C9CYP2C19PRKDC | |
| SCHEMBL21915531 | 0.80 | HSD17B1 (0.40) | CYP1A2 | |
| SCHEMBL21915527 | 0.80 | HSD17B1 (0.38) | CYP1A2 | |
| SCHEMBL21915619 | 0.79 | HSD17B1 (0.37) | NPC1CYP1A2CYP2C19RAB9APRKDC | |
| SCHEMBL21915538 | 0.78 | ALOX5 (0.39) | ALOX5PRKDC | |
| SCHEMBL21915388 | 0.78 | HSD17B1 (0.38) | NPC1RAB9A | |
| SCHEMBL15470261 | 0.77 | ALOX5 (0.47) | ALOX5CYP1A2CYP2C9CYP2C19PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020062375-A1 | 1,2,4-THIADIAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF | 武汉尚赛光电科技有限公司 | 2020-04-02 | — | — | WO | disclosed |